REGN
Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process
Wednesday, February 8, 2017 1 min read
Key Takeaway: Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process
Full Press Release Details
Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process.